Published on 14 Mar 2017
Mar.14
-- Bill Ackman has sold his entire stake in Valeant Pharmaceuticals
International Inc. and will leave the board after his Pershing Square
Capital Management lost at least $2.8 billion. Bloomberg Intelligence's
Liz Krutoholow reports on "Bloomberg Daybreak: Americas."
No comments:
Post a Comment